Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy-Reference-Cited by-同舟云学术

Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy

Published:2013-09-03 Issue:6 Volume:7 Page:1142-1151
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Kollmorgen Gwendlyn,Niederfellner Gerhard,Lifke Alexander,Spohn Gloria J.,Rieder Natascha,Vega Harring Suzana,Bauss Frieder,Burtscher Helmut,Lammers Reiner,Bossenmaier Birgit

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference21 articles.

1. The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1;Alvares;Biochim. Biophys. Acta,2008

2. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma;Awakura;J. Cancer Res. Clin. Oncol.,2008

3. The C2 domain of PKCdelta is a phosphotyrosine binding domain;Benes;Cell,2005

4. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia;Brown;J. Biol. Chem.,2004

5. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin;Buhring;Stem Cells,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiency;Clinical Immunology;2023-12

2. Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection;Emerging Microbes & Infections;2022-12-20

3. CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer;Life Sciences;2022-07

4. Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers;Journal of Clinical Investigation;2022-02-15

5. CDCP1-targeted nanoparticles encapsulating phase-shift perfluorohexan for molecular US imaging in vitro;Clinical Hemorheology and Microcirculation;2022-01-29